{"id":"abiraterone-acetate-mtd","safety":{"commonSideEffects":[{"rate":"42%","effect":"Fatigue"},{"rate":"37%","effect":"Hypertension"},{"rate":"35%","effect":"Diarrhea"},{"rate":"32%","effect":"Nausea"},{"rate":"29%","effect":"Muscle spasm"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Abiraterone acetate is a potent inhibitor of the enzyme CYP17, which is involved in the biosynthesis of androgens. By inhibiting CYP17, abiraterone acetate reduces the production of androgens, such as testosterone and dihydrotestosterone, which are involved in the growth and spread of prostate cancer cells.","oneSentence":"Androgen receptor inhibitor","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:51:50.936Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prostate cancer"}]},"trialDetails":[{"nctId":"NCT04221542","phase":"PHASE1","title":"Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer","status":"RECRUITING","sponsor":"Amgen","startDate":"2020-03-04","conditions":"Prostate Cancer","enrollment":479},{"nctId":"NCT07104617","phase":"PHASE1, PHASE2","title":"Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）","status":"NOT_YET_RECRUITING","sponsor":"TYK Medicines, Inc","startDate":"2025-08","conditions":"Metastatic Castration-resistant Prostate Cancer (mCRPC)","enrollment":48},{"nctId":"NCT01553188","phase":"PHASE2","title":"AMG 386 and Abiraterone for Advanced Prostate Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2012-02-08","conditions":"Prostatic Neoplasms, Prostate Cancer, Neoplasm, Prostate","enrollment":36},{"nctId":"NCT01717898","phase":"PHASE1, PHASE2","title":"A Multicenter Phase I/II Trial of Abiraterone Acetate + BEZ235 in Metastatic, Castration-Resistant Prostate Cancer","status":"TERMINATED","sponsor":"Charles Ryan","startDate":"2013-01-31","conditions":"Castrate-resistant Prostate Cancer","enrollment":6},{"nctId":"NCT01511536","phase":"PHASE1, PHASE2","title":"Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2012-03","conditions":"Prostate Cancer","enrollment":38},{"nctId":"NCT00473746","phase":"PHASE1, PHASE2","title":"Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2006-06","conditions":"Prostate Neoplasms","enrollment":66},{"nctId":"NCT00473512","phase":"PHASE1, PHASE2","title":"A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy","status":"COMPLETED","sponsor":"Cougar Biotechnology, Inc.","startDate":"2005-11","conditions":"Prostatic Neoplasms","enrollment":54},{"nctId":"NCT01664728","phase":"PHASE1","title":"An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2007-04","conditions":"Prostate Neoplasms","enrollment":54}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CB7630"],"phase":"phase_1","status":"active","brandName":"Abiraterone acetate MTD","genericName":"Abiraterone acetate MTD","companyName":"Cougar Biotechnology, Inc.","companyId":"cougar-biotechnology-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Androgen receptor inhibitor Used for Prostate cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}